Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07679776

Enrollment

100

Registered

2026-07-01

Start date

2025-01-01

Completion date

2026-06-30

Last updated

2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus (SLE), Visual Function

Brief summary

* OCT, OCTA, fundus photography, and fundus autofluorescence ( FAF ) were used to observe the fundus physiological indexes of normal subjects and SLE patients, to explore the differences of subclinical retinal damage in SLE patients with different degrees of disease activity, to summarize the changes of subclinical retina in SLE patients without organic retinopathy, and to evaluate its correlation with disease activity, which is of great significance for improving the prognosis of visual function and improving the quality of life in SLE patients. * By evaluating the visual psychophysical indicators, mainly the visual function test results of different colors and different frequencies, reflecting the functional status of the retina and the degree and characteristics of functional impairment in SLE patients with different degrees of disease activity, in order to screen out the clinical markers of SLE fundus lesions, and provide a reliable reference for the prevention and early intervention of visual impairment.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* the best corrected visual acuity ( BCVA ) of all cases must be ≥ 1.0 according to the international standard visual acuity char; * intraocular pressure ( IOP ) in the normal range, namely 10 mmHg ≤ IOP ≤ 21 mmHg ; * visual field meter examination center and peripheral visual field without defect ; * no degeneration of fundus retina ;

Exclusion criteria

* obvious abnormality in cranial MRI ; * history of glaucoma, cataract, retinal vascular disease, retinitis pigmentosa and other eye diseases ; * history of refractive surgery such as corneal refractive surgery and cataract surgery ; * other major disease history or systemic lesions affecting the eye ; * history of disease affecting cognitive function, can understand and cooperate with the examination.

Design outcomes

Primary

Measure	Time frame
contrast sensitivity	Day 1

Countries

China

Outcome results